The Effects of Luo-Bu-Fu-Ke-Bi-RI Pill

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05846698

Enrollment

300

Registered

2023-05-06

Start date

2021-09-05

Completion date

2025-06-25

Last updated

2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Climacteric Syndrome

Brief summary

To investigate the effect of LBFKBRP on climacteric syndrome in women and explore its therapeutic mechanism.

Interventions

DRUGLuo-Bu-Fu-Ke-Bi-RI Pill

10 pills twice daily

DRUGtibolone

2.5 mg once daily

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

41 Years to 60 Years

Healthy volunteers

Inclusion criteria

Clinical diagnosis of climacteric syndrome

Design outcomes

Primary

Measure	Time frame
Sex hormone	3 month

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026